DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ shed 1.00% to $843.47 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.06% to 7,747.71 and the Dow Jones Industrial Average rising 1.18% to 53,686.11.
The stock's fall snapped a three-day winning streak.
Regeneron Pharmaceuticals Inc. closed 1.29% below its 52-week high of $854.49, which the company reached on September 2nd.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Amgen Inc. $(AMGN)$ rose 0.29% to $444.12, Moderna Inc. (MRNA) fell 1.29% to $148.87, and Gilead Sciences Inc. (GILD) rose 1.08% to $151.22.
Trading volume (494,871) remained 279,833 below its 50-day average volume of 774,704.
Data source: Dow Jones Market Data, FactSet. Data compiled September 3, 2026.